SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-018889
Filing Date
2022-07-08
Accepted
2022-07-08 16:04:33
Documents
12
Period of Report
2022-07-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51392
  Complete submission text file 0001493152-22-018889.txt   225356

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20220705.xsd EX-101.SCH 3036
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20220705_lab.xml EX-101.LAB 34476
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20220705_pre.xml EX-101.PRE 22597
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3623
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 221074403
SIC: 2834 Pharmaceutical Preparations